Joining Forces: Bmi1 Inhibition and Cisplatin Curb Squamous Carcinogenesis
- PMID: 28475877
- DOI: 10.1016/j.stem.2017.04.008
Joining Forces: Bmi1 Inhibition and Cisplatin Curb Squamous Carcinogenesis
Abstract
Head and neck squamous cell carcinomas (HNSCCs) are refractory to therapeutic interventions. Chen et al. (2017) show that mouse and human HNSCCs and their metastases depend on Bmi1-expressing cancer stem cells and AP1 signaling and that simultaneously inhibiting Bmi1 or AP1, combined with Cisplatin, reduces tumor growth effectively in preclinical models.
Copyright © 2017 Elsevier Inc. All rights reserved.
Comment on
-
Targeting BMI1+ Cancer Stem Cells Overcomes Chemoresistance and Inhibits Metastases in Squamous Cell Carcinoma.Cell Stem Cell. 2017 May 4;20(5):621-634.e6. doi: 10.1016/j.stem.2017.02.003. Epub 2017 Mar 9. Cell Stem Cell. 2017. PMID: 28285905 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
